The Global branched stent grafts market was valued worth USD 0.28bn in 2021 and is projected to be valued at USD 0.47bn by 2028, growing at a CAGR of 8.0%.
The global branched stent-grafts market expanded at a CAGR of 8.0%. between 2021 to 2028. The market has been ever-growing for the past few decades, the reason being the increasing number of coronary heart diseases. Further, the rising geriatric population will also drive the market over the forecast period.
ResearchMoz report delivers an in-depth analysis of the global stent
grafts interface marketplace, including its size, key drivers for growth, major
opportunities and challenges it faces along with the regional segments that
will experience significant expansion over time.
Polymer-Based Technology to Drive the Branched Stent Grafts Market
Recently, polymer-based technologies have been recommended as an
alternative to fix abdominal aortic aneurysms (AAA). There are two categories
under this technology- one is Endovascular Aneurysm Sealing (EVAS), which uses
polymer filled end bags and Nellix Stent Grafts. The second, EVAR, uses a thin
neoprene-based neck sealing device that’s also called the Ovation stent graft.
EVAS was not successful despite being in use for some time now but EVAR has
established itself as safe and effective; leading to the expansion of the
global branched stents market.
Growing Vascular Surgeries Boost Demand
The growing number of vascular surgeries are driving the global
branched stent grafts market and will continue during the forecast period. This
is primarily due to the growing geriatric population across the globe and
growing cases of coronary heart diseases.
However, the
poor durability of metallic grafts will impede the growth during the forecast
period.
Nonetheless,
the rising demand for biocompatible stents will allow the market to grow
exponentially in the coming years.
The players in the global branched stent-grafts market include-
- Abbott
- Cook
Medical
- Eucatech
AG
- Merit
Medical Systems
- Endocor
GmbH
- Boston
Scientific Corp.
- Terumo
Corp.
- Medtronic
- Biotronik
- Alvimedica
- Cardinal
Health (Cordis)
Type Outlook (Revenue, USD
Billion)
- Sutures
- Wire & Mesh
- Iliac Stent
- Others
Application Outlook (Revenue, USD
Billion)
- EVAR
- FEVAR
- Chimney
- Others
Regional Outlook
North America
- U.S.
- Canada
Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Greece
- The Netherlands
Asia Pacific
- Japan
- China
- India
Latin America
- Mexico
- Brazil
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Comments
Post a Comment